학술논문

Lung Cancer Driven by BRAFG469V Mutation Is Targetable by EGFR Kinase Inhibitors
Document Type
Article
Source
In Journal of Thoracic Oncology February 2022 17(2):277-288
Subject
Language
ISSN
1556-0864